Urinary urgency and the associated symptoms which comprise overactive bladder are prevalent amongst the general population and adversely affect quality of life. Disease management consists of a sequential series of options starting with behavioural and lifestyle techniques, pharmacological management (antimuscarinics) and, in severe cases, surgical treatment (urinary diversion, neuromodulation, augmentation cystoplasty and detrusor myectomy). There is increasing recognition of pathophysiological mechanisms in the urothelium, interstitial cells and afferent neurons allowing the importance of peripheral integrative interaction to be identified. The hierarchy of the central nervous system control adds additional complexity to understanding the oflower urinary tract function. Some newer methods of treatment include Botulinum toxin A intramural injections, oral beta-3 adrenergic agonists and rho-kinase inhibitors. The lack of a disease generating hypothesis, the lack of animal models for disease and the subjective nature of the central symptom (urgency) still pose considerable theoretical and scientific hurdles that need to be overcome in the treatment of this condition.
Introduction
Overactive bladder syndrome (OAB) is the presence of urinary urgency, usually with frequency and nocturia, in the absence of other causes of similar symptoms. It is essential to consider urinary tract infection or pelvic malignancy as a potential cause. The following are definitions of some of the key terms [Abrams et al. 2002]: 1. Urgency: the complaint of a sudden compelling desire to pass urine, which is difficult to defer. 2. Detrusor overactivity (DO): a urodynamic observation characterized by involuntary detrusor contractions during the filling phase, which may be spontaneous or provoked (Figure 1 ). 3. Increased daytime frequency: a complaint by the patient who considers that he/she voids too often by day. 4. Nocturia: the complaint that the individual has to wake at night one or more times to void.
If there is associated urgency incontinence, the term 'OAB wet' can be used; if there is no urgency incontinence then the term 'OAB dry' is appropriate [Stewart et al. 2003 ]. Urgency is the symptom with greatest impact on quality of life [Coyne et al. 2008 ] and hence is one of the main issues with regards to the clinical management. It is important to note that not all patients present with both frequency and urgency. In fact, frequency might in some people be a compensatory mechanism by which the bladder is prevented from filling to a volume where urgency occurs. As a result some patients may present with minimal urgency, despite urgency being the defining symptom of OAB; they will, though, manifest frequent voiding of small volumes.
Lower urinary tract symptoms (LUTS) in general are highly prevalent [Coyne et al. 2009 ] while it is estimated that the prevalence of OAB is approximately 12%, increasing with age, and somewhat similar prevalence in males and females ]. As far as the financial cost is concerned, OAB has a significant impact, costing billions of euros for clinical, social and occupational management [Reeves et al. 2006 ].
Diagnosis and evaluation
In order to make a diagnosis of OAB, one has to take into consideration potential confounding conditions involved, particularly urinary tract infection (UTI), and occasionally include endocrine, malignant neurological problems. The history should establish the presence of urgency and also address the association with other storage and voiding phase symptoms, and their severity.
An abdominal and pelvic examination should be done to rule out any abdominal or pelvic masses in the female patients, and to evaluate prostatic enlargement or malignancy in male patients. Neurological examination should be done to rule out neurological pathology. A simple bedside urine test (dipstick urinalysis) or a sample sent for microscopy, culture and sensitivity should be used to exclude a urinary tract infection. Another simple investigation is the bladder diary which enables the patient to document urinary frequency, the number of episodes of nocturia and the input and output [Abrams and Klevmark, 1996] . The bladder diary offers the clinician a useful tool, providing vital documentation when comparing the condition before and after treatment. Bladder diaries can be combined with simple 'urgency scales', of which several have been put forward [Starkman and Dmochowski, 2008] . Other useful investigations include an ultrasound scan to assess the entire urinary tract and to measure the postresidual volumes. Ultrasound can rule out other causes of urgency such as pelvic masses or urolithiasis. Evaluation of flow rates and postresidual volumes is appropriate in some cases, because of the potential coexistence of OAB with voiding problems. Both bladder outlet obstruction and detrusor underactivity cause voiding symptoms and can give rise to a high post void residual (PVR), potentially complicating the evaluation and management of OAB.
The use of questionnaire-based tools in assessing and quantifying severity of symptoms helps to supplement the information gathered by the clinician [Basra and Kelleher, 2007] . In recent times, there has been an improvement in the logical and methodical develop of questionnaires, highlighted by advances by the International Consultation on Incontinence Modular Questionnaires (ICIQs) [Irwin et al. 2008; Abrams et al. 2006a ]. The ICIQs have included recognized questionnaires, while developing and validating newer ones across the range of LUTS. This allows for a greater flexibility on the part of the clinician.
Standard first-line treatment of OAB
The initial therapy options include the following:
1. Fluid management. Advice on the quantity and types of fluids that should be taken. A decrease in the volume of fluids consumed may improve the symptom [Swithinbank, 2005] . This advice is part of supporting the patient's coping strategies [Irwin et al. 2008 ]. 2. Bladder training. This aims to develop control of the bladder. The patient is asked to defer passing urine far a short term after the onset of urgency, increasing the length of time steadily over a period of several weeks. Training is safe and can have some initial benefit [Wallace et al. 2004] , with or without pelvic floor muscle exercise training [Hay-Smith and Dumoulin, 2006] , although the evidence on which to base this recommendation is not strong. There is a high relapse rate associated with bladder retraining and other lifestyle changes, and for this reason it is recommended that the patient is kept under follow up. 3. Timed voiding. Some patients develop urgency when their bladder capacity reaches a particular volume. In order to prevent this crucial volume being attained, the patient is encouraged to void at regular intervals, hence Therapeutic Advances in Urology 2 (4) pre-empting the onset of urgency and urge incontinence [Ouslander et al. 2000] . In older or cognitively impaired people, prompted voiding can achieve the same ends, in which a carer reminds the patient to go to the toilet. However, OAB in older individuals may be a manifestation of multifactorial changes of aging, which means each person must be evaluated accordingly, to derive a suitable therapeutic strategy. , 1998 ], in which the bladder is transacted and repaired with a patch of ileum isolated from the small intestine. This is a major procedure, with risk of major operative morbidity and long-term consequences including need for intermittent catheterization, infections, perforation, malignancy, bowel dysfunction and renal failure. Long-term efficacy is also uncertain [Hasan et al. 1995a ]. 3. Another surgical option is detrusor myectomy (autoaugmentation), which requires removal of the bulk of the bladder muscle, leaving a thin-walled reservoir comprising predominantly urothelium [Swami et al. 1998 ]. Long-term benefits have been reported [Kumar and Abrams, 2005] , but the procedure is not widely employed and it only warranted a grade D recommendation by the fourth International Consultation on Incontinence [Abrams et al. 2010]. 4. Urinary diversion is undertaken in severe cases following careful consideration. The evidence base as to outcome in these patients is very limited [Yong et al. 2003 ].
In theory, reduction of afferent nerve information would reduce sensory information, and might improve severity of this sensory-based diagnosis.
Examples include prolonged bladder distension [Pengelly et al. 1978] , bladder transection [Hasan et al. 1995a [Hasan et al. , 1995b surgical denervation [Cespedes et al. 1996 ] and chemical denervation [Chapple et al. 1991] . While initial results were sometimes good, long-term outcomes were unsatisfactory [Madersbacher, 2000] . Furthermore, substantial complications have been reported, so they are no longer recommended by expert bodies. There is more than one formulation of BoNT-A available (e.g. Dysport and Botox), and they are not dose equivalent. Currently BoNT-A provides the patient with refractory OAB with a treatment option providing that they are willing to take the risk of urinary retention and self-catheterization, and accept the risks of undergoing an unlicensed treatment without long-term clinical trial evidence.
Botulinum injections

Basic science
The pathophysiological basis of OAB needs to be able to explain both increased filling sensation and DO. As DO is objectively demonstrable urodynamically, with similar observations apparent in animal models, it has been more extensively studied scientifically, but more recent work has highlighted afferent mechanisms in view of the sensory basis of the OAB diagnosis.
The neurogenic hypothesis of DO deals with the changes in central nervous system (CNS) pathways, leading to imbalance that tends to increase bladder excitation, reduce inhibition and increase afferent input. Damage to central inhibitory pathways or sensitization of peripheral afferent terminals in the bladder can unmask primitive voiding reflexes that trigger bladder overactivity [de Groat, 1997] . The myogenic hypothesis [Brading and Turner, 1994] suggests that partial denervation of the detrusor causes an alteration of the properties of the smooth muscle ('denervation supersensitivity'), leading to increased spontaneous excitability. In addition, propagation of excitation over abnormal large distances allows spread of spontaneous excitation to affect a greater proportion of the bladder. Alterations in the functional properties of detrusor myocytes is seen in DO [Brading, 1997] , but not in all contexts [Mills et al. 2000 ]. The integrative hypothesis suggests that spontaneous localized contractions (micromotions) are a normal physiological mechanism for reporting the state of bladder filling, determined by interactions of the various functional cell types in the bladder wall (e.g. interstitial cells). Alterations in the properties or interactions of any of these cells will lead to exaggerated micromotions, thence OAB, and/or excessive propagation, [Roosen et al. 2009 ] have substantial effects in integrative bladder function. In isolated rodent bladder, ICs drive autonomous activity [Lagou et al. 2006] , and comprehending the underlying mechanisms may help develop possible treatment options [de Jongh et al. 1997a [de Jongh et al. , 2007 . 5. CNS. The CNS reflexes orchestrate the joint activity of the bladder outlet and the bladder, and integrate the processes into overall vegetative function [de Groat, 2006 ]. When urine is stored the higher centres inhibit the lower spinal reflexes [Jiang et al. 2008] . With the emergence of new in vivo imaging technology, insight into the affective and subjective elements of OAB may become realistic [Drake et al. 2010; Fowler and Griffiths, 2010] . Furthermore there are clear changes in the CNS comprising altered activation and disinhibition of some centres in people with LUTS [Tadic et al. 2008] .
Key challenges
The main symptom of OAB is urgency, which defines the condition. However, there is a subjective aspect in measuring urgency which hinders research. In some cases the objective and subjective aspects do not correlate. In addition, the objective measurement of the severity of the problem is sometimes difficult to assess, complicating development of robust outcome measures for clinical trials necessary for regulatory approval of new forms of treatment. Urodynamics has been used in the past, since it demonstrates DO objectively. However, not all patients with urgency have DO [Hashim and Abrams, 2006 ]. Some patients with DO undergoing ambulatory urodynamic studies fail to show urgency [Bristow and Neal, 1996] . Furthermore, there are no true animal models of OAB, hindering scientific and clinical progress.
There are many factors that attribute to the pathophysiology of OAB. The function of the lower urinary tract is determined by a complex neural hierarchy of the peripheral nervous system and CNS. While patients may appear to have similar symptoms, in reality the underlying mechanisms may be diverse. Ultimately, the problem is incurable; no strategy causes an overactive bladder to revert to 'normality'.
Conclusions
Conservative management, supplemented by antimuscarinic drugs, should be instigated following simple evaluation. Where symptoms persist, urodynamic diagnosis is appropriate. A number of invasive treatments are available, but the evidence base is patchy and potential morbidity and cost can be substantial. Development of new treatments based on a growing wealth of experimental data is promising, but many challenges remain.
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